Samuel D. Banister

4.4k total citations · 1 hit paper
99 papers, 3.5k citations indexed

About

Samuel D. Banister is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Samuel D. Banister has authored 99 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pharmacology, 52 papers in Cellular and Molecular Neuroscience and 45 papers in Molecular Biology. Recurrent topics in Samuel D. Banister's work include Cannabis and Cannabinoid Research (57 papers), Forensic Toxicology and Drug Analysis (38 papers) and Neurotransmitter Receptor Influence on Behavior (28 papers). Samuel D. Banister is often cited by papers focused on Cannabis and Cannabinoid Research (57 papers), Forensic Toxicology and Drug Analysis (38 papers) and Neurotransmitter Receptor Influence on Behavior (28 papers). Samuel D. Banister collaborates with scholars based in Australia, United States and New Zealand. Samuel D. Banister's co-authors include Michael Kassiou, Mark Connor, Iain S. McGregor, Michelle Glass, Mitchell Longworth, Richard C. Kevin, Roy Gerona, Corinne Beinat, Jordyn Stuart and Shane M. Wilkinson and has published in prestigious journals such as New England Journal of Medicine, Cell and SHILAP Revista de lepidopterología.

In The Last Decade

Samuel D. Banister

99 papers receiving 3.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex

2019 318 citations Samuel D. Banister et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samuel D. Banister Australia	33	2.0k	1.6k	1.4k	1.1k	488	99	3.5k
Bruce E. Blough United States	38	684 0.3×	1.5k 1.0×	2.8k 2.0×	1.7k 1.6×	1.1k 2.3×	176	4.8k
Patricia H. Reggio United States	44	4.0k 2.0×	514 0.3×	2.9k 2.1×	2.6k 2.4×	246 0.5×	132	5.9k
Dow P. Hurst United States	33	2.2k 1.1×	311 0.2×	1.7k 1.2×	1.7k 1.6×	155 0.3×	71	3.3k
Andrew Coop United States	32	457 0.2×	453 0.3×	1.5k 1.0×	1.9k 1.8×	212 0.4×	154	4.6k
Herbert H. Seltzman United States	27	1.3k 0.6×	261 0.2×	1.1k 0.8×	836 0.8×	129 0.3×	82	2.2k
Elena Escubedo Spain	31	339 0.2×	1.0k 0.6×	1.6k 1.1×	993 0.9×	609 1.2×	114	2.7k
Vincent Setola United States	33	676 0.3×	317 0.2×	1.8k 1.2×	2.8k 2.6×	471 1.0×	81	5.1k
Aaron Janowsky United States	43	649 0.3×	521 0.3×	3.5k 2.5×	2.6k 2.4×	473 1.0×	129	5.5k
S. Michael Owens United States	33	600 0.3×	677 0.4×	1.2k 0.9×	1.2k 1.1×	145 0.3×	107	2.9k
Christopher J. Schmidt United States	39	1.6k 0.8×	750 0.5×	2.5k 1.8×	2.7k 2.5×	674 1.4×	80	4.8k

Countries citing papers authored by Samuel D. Banister

Since Specialization

Citations

This map shows the geographic impact of Samuel D. Banister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel D. Banister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel D. Banister more than expected).

Fields of papers citing papers by Samuel D. Banister

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel D. Banister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel D. Banister. The network helps show where Samuel D. Banister may publish in the future.

Co-authorship network of co-authors of Samuel D. Banister

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel D. Banister. A scholar is included among the top collaborators of Samuel D. Banister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel D. Banister. Samuel D. Banister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Timmerman, Axelle, Rochelle Boyd, Richard C. Kevin, et al.. (2024). Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA. ACS Chemical Neuroscience. 15(9). 1787–1812. 2 indexed citations

Patel, Monica, Natasha L. Grimsey, Samuel D. Banister, David B. Finlay, & Michelle Glass. (2023). Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB₂ receptor. Pharmacology Research & Perspectives. 11(6). e01157–e01157. 7 indexed citations

Boyd, Rochelle, Felcia Lai, Roy Gerona, et al.. (2022). Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA. ACS Chemical Neuroscience. 14(1). 35–52. 6 indexed citations

Cairns, Elizabeth A., Richard C. Kevin, Felcia Lai, et al.. (2021). Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA. RSC Medicinal Chemistry. 13(2). 156–174. 21 indexed citations

Grafinger, Katharina Elisabeth, Annelies Cannaert, Jia Lin Luo, et al.. (2021). Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB₁ receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB₁ receptors. Drug Testing and Analysis. 13(7). 1383–1401. 29 indexed citations

Grafinger, Katharina Elisabeth, Annelies Cannaert, Elizabeth A. Cairns, et al.. (2021). Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB₁ receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay. Drug Testing and Analysis. 13(7). 1402–1411. 32 indexed citations

Cairns, Elizabeth A., Katharina Elisabeth Grafinger, Annelies Cannaert, et al.. (2021). NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?. ACS Chemical Neuroscience. 12(21). 4020–4036. 8 indexed citations

Grafinger, Katharina Elisabeth, Marthe M. Vandeputte, Annelies Cannaert, et al.. (2021). Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays. Drug Testing and Analysis. 13(7). 1412–1429. 20 indexed citations

Cannaert, Annelies, Jia Lin Luo, Richard C. Kevin, et al.. (2020). Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA. ACS Chemical Neuroscience. 11(24). 4434–4446. 78 indexed citations

10.

Vandesquille, Matthias, Marie‐Claude Asselin, C. Prenant, et al.. (2020). Evaluation of ¹⁸F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration in vivo in rodents and in human tissue. Theranostics. 10(18). 7938–7955. 10 indexed citations

11.

Sachdev, Shivani, Kiran Vemuri, Samuel D. Banister, et al.. (2019). In vitro determination of the efficacy of illicit synthetic cannabinoids at CB ₁ receptors. British Journal of Pharmacology. 176(24). 4653–4665. 39 indexed citations

12.

Wouters, Elise, et al.. (2019). Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists. Biochemical Pharmacology. 169. 113623–113623. 69 indexed citations

13.

Monte, Andrew A., Andrew Hopkinson, Jessica L. Saben, et al.. (2019). The Psychoactive Surveillance Consortium and Analysis Network (PSCAN): the first year. Addiction. 115(2). 270–278. 14 indexed citations

14.

Banister, Samuel D., Axel Adams, Richard C. Kevin, et al.. (2018). Synthesis and pharmacology of new psychoactive substance 5F‐CUMYL‐P7AICA, a scaffold‐ hopping analog of synthetic cannabinoid receptor agonists 5F‐CUMYL‐PICA and 5F‐CUMYL‐PINACA. Drug Testing and Analysis. 11(2). 279–291. 47 indexed citations

15.

Banister, Samuel D. & Mark Connor. (2018). The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins. Handbook of experimental pharmacology. 252. 165–190. 70 indexed citations

16.

Palner, Mikael, Corinne Beinat, Samuel D. Banister, et al.. (2016). Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor. EJNMMI Research. 6(1). 80–80. 8 indexed citations

17.

Beinat, Corinne, Samuel D. Banister, Marco Herrera‐Barrera, & Michael Kassiou. (2016). The Recent Development of α₇ Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases. Current Pharmaceutical Design. 22(14). 2134–2151. 4 indexed citations

18.

Beinat, Corinne, Samuel D. Banister, John Tsanaktsidis, et al.. (2014). Structure–activity relationships of N-substituted 4-(trifluoromethoxy)benzamidines with affinity for GluN2B-containing NMDA receptors. Bioorganic & Medicinal Chemistry Letters. 24(3). 828–830. 19 indexed citations

19.

Ribeiro, Maria-Joao Santiago, Johnny Vercouillie, Séverine Debiais, et al.. (2014). Could 18 F-DPA-714 PET imaging be interesting to use in the early post-stroke period?. EJNMMI Research. 4(1). 28–28. 34 indexed citations

20.

Beinat, Corinne, Samuel D. Banister, Munikumar Reddy Doddareddy, et al.. (2012). Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333. Bioorganic & Medicinal Chemistry Letters. 22(7). 2380–2384. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact